Audiowell Involved in Formulating Key Medical Device Group Standard – "Group Standard for Ultrasonic
Release Time：2025-07-23 Reads：27
The "Group Standard for Ultrasonic Soft Tissue Surgical Equipment Transducers" (T/CIET 1203-2025), spearheaded by the Standardization Work Committee of the China International Economic and Technical Cooperation Promotion Association, has been released and implemented. Audiowell Electronics (Guangdong) Co., Ltd.?, as one of the core drafting units, leveraged its profound technical expertise and industry influence in the field of precision ultrasonic transducers to participate comprehensively and deeply in the formulation of this key standard.
This group standard focuses on the transducer – the core component of ultrasonic soft tissue surgical devices – establishing scientific, systematic, and forward-looking definitions for key technical indicators such as performance requirements, test methods, and inspection rules. As the "core component" of the equipment, the performance of the ultrasonic transducer directly determines the precision of the devices energy output and the safety and efficacy of surgical procedures. The standard provides a unified and authoritative technical benchmark for product R&D, production, quality inspection, and clinical application, which will effectively drive the technological upgrade of domestic high-end ultrasonic surgical equipment and the standardization of the market.
During the standard formulation process, Audiowells technical expert team, drawing upon extensive R&D experience and strict production practices, actively contributed professional insights. They provided constructive technical proposals and practical data support, particularly in setting key performance parameters and defining reliability verification methods, ensuring the standards scientific rigor, advancement, and practicality.
Audiowells deep involvement in formulating this national-level group standard highlights the companys technological leadership and industry responsibility within the field of core medical ultrasonic components. The company will seize this opportunity to continue driving innovation breakthroughs and the industrialization process for core technologies in domestic high-end medical devices.